Zevra Therapeutics, Inc. ZVRA Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s treasury stock, value?
- Zevra Therapeutics, Inc. (ZVRA) reported treasury stock, value of $10.98M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s treasury stock, value changed year-over-year?
- Zevra Therapeutics, Inc.'s treasury stock, value decreased by 0.0% year-over-year, from $10.98M to $10.98M.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.